Chuanhua Zhao
ORCID：0000-0001-7698-9618
发表论文 82 篇 · 总被引 701 次 · h-index 15
代表论文
- Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 20)
- Preliminary results of a phase I, first-in-human, dose escalation study of IMM2902 in patients with HER2-expressing advanced solid tumors. (2023 · Journal of Clinical Oncology · 被引 7)
- The novel HLA‐B*51:389 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual (2024 · HLA · 被引 3)
- Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity (2025 · Molecular Cancer Therapeutics · 被引 2)
- Correlation Between Treatment‐Related Adverse Events and Efficacy of Camrelizumab in Combination With Apatinib in Patients With Unresectable Hepatocellular Carcinoma (2025 · Cancer Medicine · 被引 1)
- 558 Preclinical profile of STAR-0310, a novel OX40 antagonistic monoclonal antibody (2024 · Journal of Investigative Dermatology · 被引 1)